Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic Adenoviruses
- 1 December 2003
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 65 (3) , 237-246
- https://doi.org/10.1023/b:neon.0000003653.45635.32
Abstract
Adenoviruses have been critical in the development of the molecular approaches to brain tumors. They have been engineered to function as vectors for delivering therapeutic genes in gene therapy...Keywords
This publication has 87 references indexed in Scilit:
- Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma PathwayJNCI Journal of the National Cancer Institute, 2003
- A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancerCancer Gene Therapy, 2002
- Clinical evaluation of adenoviral-mediated p53 gene transfer: Review of INGN 201 studiesSeminars in Oncology, 2001
- Human Papillomavirus E6E7-Mediated Adenovirus Cell Killing: Selectivity of Mutant Adenovirus Replication in Organotypic Cultures of Human KeratinocytesJournal of Virology, 2001
- E1B-Deleted Adenovirus (dl1520) Gene Therapy for Patients with Primary and Secondary Liver TumorsHuman Gene Therapy, 2001
- Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumorsCancer Gene Therapy, 2000
- Adenovirus-mediated p53 Gene Therapy for Human GliomasNeurosurgery, 1999
- Gene therapy of cancerImmunology Today, 1998
- Safety Evaluation of Ad5CMY-p53 In VitroandIn VivoHuman Gene Therapy, 1995
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989